In this light, one of its analogs, octreotide, whose binding activity is limited to SSR2 and 5, seems to be able to inhibit the production of TNFα (31) and to increase the production of Interleukin-10 (IL-10) in patients with autoimmune diseases (32). Here, IL10 is linked to autoimmune disease.